Patent applications and USPTO patent grants for CHS Pharma Inc..The latest application filed is for "treatment for ischemic stroke".
Patent | Date |
---|---|
Treatment For Ischemic Stroke App 20210138021 - Wu; Jang-Yen | 2021-05-13 |
Treatment for ischemic stroke Grant 10,945,986 - Wu , et al. March 16, 2 | 2021-03-16 |
Granulocyte Colony-stimulating Factor (gcsf) Gene Therapy For Treating Neurological Diseases App 20210052745 - Wu; Jang-Yen | 2021-02-25 |
Retinopathy treatment Grant 10,792,260 - Blanks , et al. October 6, 2 | 2020-10-06 |
Treatment for Ischemic Stroke App 20190209512 - Wu; Jang-Yen ;   et al. | 2019-07-11 |
Treatment for ischemic stroke Grant 10,272,063 - Wu , et al. | 2019-04-30 |
Treatment for Ischemic Stroke App 20180055809 - Wu; Jang-Yen ;   et al. | 2018-03-01 |
Treatment for ischemic stroke Grant 9,827,220 - Wu , et al. November 28, 2 | 2017-11-28 |
Use Of Sulindac For Protecting Retinal Pigment Epithelial Cells Against Oxidative Stress App 20170143653 - Prentice; Howard M. ;   et al. | 2017-05-25 |
Retinopathy Treatment App 20160074350 - Blanks; Janet C. ;   et al. | 2016-03-17 |
Treatment for Ischemic Stroke App 20150265569 - Wu; Jang-Yen ;   et al. | 2015-09-24 |
Treatment for ischemic stroke Grant 9,050,305 - Wu , et al. June 9, 2 | 2015-06-09 |
Protection of normal cells Grant 8,871,971 - Weissbach , et al. October 28, 2 | 2014-10-28 |
Treatment or prevention of cancer and precancerous disorders Grant 8,765,808 - Weissbach , et al. July 1, 2 | 2014-07-01 |
Protection Of Normal Cells App 20140018429 - Weissbach; Herbert ;   et al. | 2014-01-16 |
Treatment or prevention of cancer and precancerous disorders Grant 8,603,985 - Weissbach , et al. December 10, 2 | 2013-12-10 |
Protection of normal cells Grant 8,487,128 - Weissbach , et al. July 16, 2 | 2013-07-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.